• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Fresh2 Group Limited filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits

    3/25/24 4:05:33 PM ET
    $FRES
    Medical Specialities
    Health Care
    Get the next $FRES alert in real time by email
    false 0001786511 00-0000000 0001786511 2023-12-08 2023-12-08 0001786511 FRES:AmericanDepositarySharesEachRepresenting20ClassOrdinarySharesParValueUs0.01PerShareMember 2023-12-08 2023-12-08 0001786511 FRES:ClassOrdinaryShareParValueUs0.01PerShareMember 2023-12-08 2023-12-08 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): December 8, 2023

     

    Fresh2 Group Limited
    (Exact name of registrant as specified in its charter)

     

    British Virgin Islands   001-39137   Not Applicable
    (State or other jurisdiction
    of incorporation)
      (Commission File Number)   (IRS Employer
    Identification No.)

     

    650 5TH AVE STE 2416

    NEW YORK,

    United States

      NY 10019-6108
    (Address of principal executive offices)   (Zip Code)

     

    Registrant’s telephone number, including area code: 917-397-6890

     

    Not Applicable
    (Former name or former address, if changed since last report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    American depositary shares (each representing 20 Class A ordinary shares, par value US$0.01 per share)   FRES   Nasdaq Capital Market
    Class A ordinary share, par value US$0.01 per share        

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ☐

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

     

     

     

     

     

    Item 1.01. Entry into a Material Definitive Agreement.

     

    Amendment to the December 2022/January 2023 Agreements

     

    As previously reported, in December 2022 and January 2023, Fresh2 Group Limited (the “Company”) entered into investment agreements with several third party investors, whereby the investors purchased 29,714,279 newly issued Class A ordinary shares (1,485,714 American Depositary Shares or “ADSs”) of the Company at a price of $0.175 per ordinary share or $3.50 per ADS (1:20 ADS-to-share ratio), for a total purchase price of $5.2 million. For each Class A ordinary share purchased, the investors were to receive two warrants with each warrant to purchase one Class A ordinary share at an exercise price of $0.21 per ordinary share (2,971,428 ADS an at exercise price of $4.20 per ADS). The warrants were to be exercisable within 2 years from the date of issuance. On March 8, 2023, two additional third-party investors invested an additional $205,000 under the same terms (collectively referred to as the “Transactions”).

     

    From December 2023 to March 2024, the Company entered into an Amendment to Share Purchase Agreement (the “Amendment No.1”) and a Supplemental Agreement (the “Supplemental Agreement No.1”) with each of the investors of the Transactions, whereby the Company agreed to issue an additional 46,328,557 Class A ordinary shares to the investors and the investors agreed to terminate their rights to receive the warrants. As of the effective date of the Amendments and the Supplemental Agreements, the Company had not issued any warrants to the investors. As of March 19, 2024, the Company had issued all of the additional 46,328,557 Class A ordinary shares to the investors.

     

    The foregoing description of the Amendment No.1 and the Supplemental Agreement No. 1 does not purport to be complete and is qualified in its entirety by reference to the agreements, the forms of which are filed as Exhibit 10.1 and Exhibit 10.2 hereto and are incorporated herein by reference.

     

    Amendment to the June 2023 Agreement

      

    As previously reported, June 2, 2023, the Company entered into an agreement with Applegreen LLC (“Applegreen”), under which Applegreen agreed to purchase 22,000,000 Class A ordinary shares and warrants to purchase 22,000,000 Class A ordinary shares at an aggregate purchase price of US$4.4 million. The warrants are exercisable within 2 years from the date of issuance and have an exercise price of US$4.20. The transaction closed on June 2, 2023 with Applegreen purchasing 19,500,000 Class A ordinary shares and warrants to purchase 19,500,000 Class A ordinary shares for $3.9 million. After the closing, Applegreen transferred the aforesaid shares and warrants to two individual investors, Qin Hong and Danni Zhang.

     

    On March 13, 2024, the Company entered into an amendment to the Applegreen agreement (the “Amendment No.2”) and a Supplemental Agreement (the “Supplemental Agreement No.2”), as well as a Share Purchase Agreement with each of the two investors (the “Share Purchase Agreement”), whereby the Company agreed to issue an additional 91,928,571 Class A ordinary shares to the two investors and the two investors agreed to terminate their rights to receive the warrants. On March 19, 2024, the Company issued the additional 91,928,571 Class A ordinary shares to the two investors. As a result, Qin Hong and Danni Zhang acquired 40,000,000 and 71,428,571 shares of the Company, respectively.

     

    The foregoing description of the Amendment No.2, the Supplemental Agreement No.2, and the Share Purchase Agreements does not purport to be complete and is qualified in its entirety by reference to the agreements, the forms of which are filed as Exhibit 10.3, Exhibit 10.4, Exhibit 10.5 and Exhibit 10.6 hereto and are incorporated herein by reference.

     

    Item 3.02. Unregistered sales of equity securities.

     

    The disclosure set forth in Item 1.01 above is incorporated herein by reference.

     

    Item 9.01. Financial Statement and Exhibits.

     

    Exhibit No   Document
    10.1   Form of Amendment to Share Purchase Agreement
    10.2   Form of Supplemental Agreement
    10.3   Amendment to Share Purchase Agreement, dated March 13, 2024
    10.4   Supplemental Agreement, dated March 13, 2024
    10.5   Share Purchase Agreement with Qin Hong, dated March 13, 2024
    10.6   Share Purchase Agreement with Danni Zhong, dated March 13, 2024

    104

      Cover Page Interactive Data File (embedded within the Inline XBRL document)

     

    1

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

    Dated: March 25, 2024 Fresh2 Group Limited
       
      By: /s/ Haohan Xu
      Name:  Haohan Xu
      Title: Chief Executive Officer

     

     

    2

     

    Get the next $FRES alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $FRES

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $FRES
    SEC Filings

    View All

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    12/23/24 4:02:53 PM ET
    $FRES
    Medical Specialities
    Health Care

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    11/14/24 4:15:32 PM ET
    $FRES
    Medical Specialities
    Health Care

    SEC Form 6-K filed by Fresh2 Group Limited

    6-K - Fresh2 Group Ltd (0001786511) (Filer)

    7/24/24 4:01:19 PM ET
    $FRES
    Medical Specialities
    Health Care

    $FRES
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Fresh2 Group Ltd. Announces Receipt of Staff Delisting Determination from Nasdaq; Intends to Request A Hearing

    New York, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or the "Company"), a  B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on October 16, 2024, it received a Staff Determination Letter from the Nasdaq Stock Market LLC ("Nasdaq")  indicating that the Company did not comply with Nasdaq's filing requirements as set forth in Listing Rule 5250(c)(1). The letter is a result of the Company's failure to file its Form 10-K for the year ended December 31, 2023, and its Forms 10-Q for the periods ended March 31, and June 30, 2024, within the required deadlines. Nasdaq had previously granted

    10/17/24 4:05:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Group Ltd. Announces Receipt of an Additional Delinquency Compliance Alert Notice from Nasdaq

    New York, NY, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or the "Company"), a  B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that on August 19 , 2024, it received an additional delinquency compliance alert notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") advising they have not received the Company's Form 10-Q for the period ended June 30, 2024, it does not comply with the Listing Rules 5250(c)(1) (the "Rules"), which requires the timely filing of all required periodic reports with the SEC. Previously, Nasdaq Staff had granted the Company an exception

    8/22/24 4:05:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Announces Collaboration with Over 50 Influencers in Video E-commerce

    New York, NY, July 16, 2024 (GLOBE NEWSWIRE) -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced that its video e-commerce business has partnered with over 50 influencers, resulting in continued rapid sales growth. By leveraging these key partnerships, Fresh2's video e-commerce business is rapidly expanding its market presence in the e-commerce sector. (Screenshot of some Company's venues at tiktok) The Power of Video E-commerce Unlike traditional e-commerce, video e-commerce uses multimedia formats, which offer stronger visual appeal and can hi

    7/16/24 9:15:00 AM ET
    $FRES
    Medical Specialities
    Health Care

    $FRES
    Leadership Updates

    Live Leadership Updates

    View All

    Appointment of New Independent Director

    NEW YORK, Dec. 15, 2023 /PRNewswire/ -- Fresh2 Group Ltd. (NASDAQ:FRES) ("Fresh2" or "the Company"), a B2B e-commerce and supply chain management company within the restaurant and food industry, today announced the appointment of Zhijun (Michael) Liang, as an independent director of the Company, effective January 1, 2024. Zhijun (Michael) Liang, has spent more than two decades providing management consulting and investment management services, primarily to start-ups and growth businesses, enabling them to address expansion needs and financial challenges. He co-founded Beijing Yuantong Funds Management Co., Ltd., and has led its risk and investment management since 2018. Concurrently, as the

    12/15/23 4:01:00 PM ET
    $FRES
    Medical Specialities
    Health Care

    Fresh2 Group Ltd. Appoints New Chief Strategy Officer to Drive Advancement and Execution of Long-Term Growth Strategy

    NEW YORK, July 26, 2023 /PRNewswire/ -- Fresh2 Group Ltd., formerly AnPac Bio-Medical Science Co., Ltd. (NASDAQ:FRES) ("Fresh2," the "Company" or "we"), a company with operations in the United States and China focused on the business-to-business e-commerce and supply chain sectors for the restaurant supply and food industry and on early cancer screening and detection,  today announced the appointment of Mr. Yidong Hu as its Chief Strategy Officer (CSO) effective on July 21, 2023. Mr. Hu was appointed to drive the advancement and execution of the Company's long-term strategy. Mr. Hu is a seasoned executive with over a decade of experience in the media and finance sectors. Mr.Hu has served as

    7/26/23 9:00:00 AM ET
    $FRES
    Medical Specialities
    Health Care